BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18097749)

  • 1. Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women.
    Patil DB; Lankes HA; Nayar R; Masood S; Bryk M; Hou N; Rademaker A; Khan SA
    Breast Cancer Res Treat; 2008 Nov; 112(2):327-33. PubMed ID: 18097749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal lavage findings in women with known breast cancer undergoing mastectomy.
    Khan SA; Wiley EL; Rodriguez N; Baird C; Ramakrishnan R; Nayar R; Bryk M; Bethke KB; Staradub VL; Wolfman J; Rademaker A; Ljung BM; Morrow M
    J Natl Cancer Inst; 2004 Oct; 96(20):1510-7. PubMed ID: 15494601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.
    Visvanathan K; Santor D; Ali SZ; Brewster A; Arnold A; Armstrong DK; Davidson NE; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):950-5. PubMed ID: 17507621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of cytologic intrarater and interrater reproducibility: the case of ductal lavage.
    Visvanathan K; Santor D; Ali SZ; Hong IS; Davidson NE; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2553-6. PubMed ID: 17164385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer.
    Zalles CM; Kimler BF; Simonsen M; Clark JL; Metheny T; Fabian CJ
    Breast Cancer Res Treat; 2006 May; 97(2):191-7. PubMed ID: 16322885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer.
    Bhandare D; Nayar R; Bryk M; Hou N; Cohn R; Golewale N; Parker NP; Chatterton RT; Rademaker A; Khan SA
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2620-7. PubMed ID: 16284387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.
    Higgins SA; Matloff ET; Rimm DL; Dziura J; Haffty BG; King BL
    Breast Cancer Res; 2005; 7(6):R1017-22. PubMed ID: 16280052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of breast duct lavage performed by a physician extender.
    Redlich PN; Purdy AC; Shidham VB; Yun HJ; Walker A; Ota D
    Surgery; 2004 Nov; 136(5):1077-80; discussion 1080-2. PubMed ID: 15523404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal lavage is an inefficient method of biomarker measurement in high-risk women.
    Khan SA; Lankes HA; Patil DB; Bryk M; Hou N; Ivancic D; Nayar R; Masood S; Rademaker A
    Cancer Prev Res (Phila); 2009 Mar; 2(3):265-73. PubMed ID: 19223577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient variables that predict atypical cytology by nipple duct lavage.
    Bushnaq ZI; Ashfaq R; Leitch AM; Euhus D
    Cancer; 2007 Apr; 109(7):1247-54. PubMed ID: 17326050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of nipple aspiration and ductal lavage cytology with histopathologic findings for patients before scheduled breast biopsy examination.
    West KE; Wojcik EM; Dougherty TA; Siziopikou KP; Albain KS; Gabram SG
    Am J Surg; 2006 Jan; 191(1):57-60. PubMed ID: 16399107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ductal lavage in the high-risk patient.
    Francescatti DS; Kluskens L; Shah L
    Am J Surg; 2005 Mar; 189(3):340-1. PubMed ID: 15792764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of cytologic atypia in repeat nipple duct lavage.
    Johnson-Maddux A; Ashfaq R; Cler L; Naftalis E; Leitch AM; Hoover S; Euhus DM
    Cancer; 2005 Mar; 103(6):1129-36. PubMed ID: 15685620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytology of ductal lavage fluid of the breast.
    Ljung BM; Chew KL; Moore DH; King EB
    Diagn Cytopathol; 2004 Mar; 30(3):143-50. PubMed ID: 14986293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and duct selection for nipple duct lavage.
    Maddux AJ; Ashfaq R; Naftalis E; Leitch AM; Hoover S; Euhus D
    Am J Surg; 2004 Oct; 188(4):390-4. PubMed ID: 15474432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technical enhancements to breast ductal lavage.
    Tondre J; Nejad M; Casano A; Mills D; Love S
    Ann Surg Oncol; 2008 Oct; 15(10):2734-8. PubMed ID: 18636293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
    Osborne CR; Duncan A; Sedlacek S; Paul D; Holmes F; Vukelja S; Kasper M; Wilks S; Schneider A; McGee R; Meyer WG; O'Shaughnessy JA
    Breast Cancer Res Treat; 2009 Aug; 116(3):521-7. PubMed ID: 19139988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal approaches to assessment and management of women at high risk for developing breast cancer.
    Locke I; Mitchell G; Eeles R
    Breast Cancer Res; 2004; 6(2):75-81. PubMed ID: 14979910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage.
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):827-43, viii-ix. PubMed ID: 16308095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer.
    Cazzaniga M; Severi G; Casadio C; Chiapparini L; Veronesi U; Decensi A
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1311-5. PubMed ID: 16835329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.